[1]Zhang Hang.Clinical study of docetaxel treatments for old and late stage patients with NSCLC[J].Shaanxi Medical Journal,2015,44(1):92-93.[张航.多西紫杉醇治疗老年晚期非小细胞肺癌54例临床研究[J].陕西医学杂志,2015,44(1):92-93.]
[2]Lu Kaijin,Jia Weiguang,Shen Jiangfeng,et al.Lung function and the survival rate of impact thoracoscopic lobectomy and lymph node dissection for patients with different pathological types of lung cancer[J].Practical Oncology Journal,2015,29(5):409-413.[卢开进,贾卫光,申江峰,等.胸腔镜肺叶切除术及淋巴清扫术对不同病理类型肺癌患者肺功能、生存率的影响[J].实用肿瘤学杂志,2015,29(5):409-413.]
[3]Yang Zhi,Duan Yong,Wang Zitong,et al.Clinical characteristic analysis of surgery for 53 patients with large cell lung cancer [J].Chinese Journal of Medicine,2013,48(3):68-70.[杨志,段勇,王子彤,等.手术切除肺大细胞癌53例临床特征分析[J].中国医刊,2013,48(3):68-70.]
[4]Li Junhua,Wei Hailong,Zhang Zhidong,et al.Experience of diagnosis and treatments for 12 cases of large cell lung cancer [J].Hainan Medical Journal,2010,21(21):72,76[李军华,魏海龙,张志东,等.12例肺大细胞癌的诊断与治疗体会[J].海南医学,2010,21(21):72,76.]
[5]Li Xinyu,Zhang Haiyun,He Rongqi,et al.Clinical efficacy and safety of thoracoscopic surgery[J].The Journal of Practical Medicine,2015,31(6):962-963.[李新宇,张海云,何荣琦,等.胸腔镜下行肺癌根治术的临床疗效及安全性观察[J].实用医学杂志,2015,31(6):962-963.]
[6]Wang Dongdong,Ding Cheng,Chen Jun,et al.Comparison of thoracoscopic surgery and pulmonary lobectomy for early lung cancer [J].Shandong Medical Journal,2014,54(16):61-63.[王冬冬,丁成,陈俊,等.全胸腔镜下与开胸肺叶切除术治疗早期肺癌疗效对比观察[J].山东医药,2014,54(16):61-63.]
[7]Gao Qiangfang.Study on the change of pain substance and inflammatory mediators in lung cancer patients treated with thoracoscopic resection during the perioperative period [J].The Practical Journal of Cancer,2015,30(8):1174-1176.[高强方.胸腔镜肺癌根治术患者围术期疼痛物质及炎性介质变化研究[J].实用癌症杂志,2015,30(8):1174-1176.]
[8] Onaitis MW,Petersen RP,Balderson SS,et al.Thoracoscopic iobectomy is a safe and versatile procedure:Experience with 500 consecutive patients[J].Ann Surg,2006,244:420-425.
[9] Papiashvilli M,Sasson L,Azzam S,et al.Video-assisted thoracic surgery lobectomy versus lobectomy by thoracotomy for lung cancer:Pilot study[J].Innovations(Phila),2013,8(1):6-11.
[10] Paul S,Sedrakyan A,Chiu YL,et al.Outcomes after lobectomy using thoracoscopy vs thoracotomy:A comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database[J].Eur J Cardiothorac Surg,2013,43(4):813-817.
[11] Gopaldas RR,Bakaeen FG,Dao TK,et al.Video-assisted thoracoscopic versus open thoracotomy lobectomy in a cohort of 13 619 patients[J].Ann Thorac Surg,2010,89(5):1563-1570.
[12]Hu Dingzhong,Lin Ling,Shen Yuzhou,et al.Explore the value of video-assisted-thoracoscopic lobectomy for early-stage lung cancer[J].Shanghai Medical Journal,2010,33(9):841-844.[胡定中,林凌,沈宇舟,等.全胸腔镜肺叶切除术在临床早期肺癌的应用价值[J].上海医学,2010,33(9):841-844.]
[13]Zhang Yu,Li Xin,Luo Wen,et al.Predictive value of combined detection of serum tumor markers for recurrence or metastasis of colon cancer after radical surgery[J]?Chongqing Medicine,2015,44(26):3616-3617,3621.[张瑜,李馨,骆雯,等.联合检测血清肿瘤标志物对结肠癌根治术后患者复发转移的预测价值[J]?重庆医学,2015,44(26):3616-3617,3621.]
[14]Fiala O,Pesek M,Finek J,et al.The role of neuron-specific enolase(NSE)and thimidine kinase(TK)levels in prediction of efficacy of EGFR-TKIs in patients with advanced-stage NSCLC[J].Anticancer Res,2014,34(9):5193-5198.
[15] Jiang AG,Chen HL,Lu HY.The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer[J].BMC Cancer,2015,15:386.
[16]Gong Chengxiang,Wang Mingsheng,Yao Jiaping,et al.Clinical significance of measurement the changes of serum Hcy,IGF-Ⅱ and EGF levels both before and after chemotherapy in patients with lung cancer [J].Journal of Radioimmunology,2013,26(4):401-402.[龚成香,王明生,姚加平,等.肺癌患者化疗前后血清Hcy、IGF-Ⅱ和EGF检测的临床意义[J].放射免疫学杂志,2013,26(4):401-402.]
[17]Ji Chen,Yang Zeshan,Lou Kai,et al.Immune perspective comparison of full thoracoscopy and conventional thoracotomy in lung cancer radical surgery [J].Journal of Medical Research,2013,42(1):107-110.[继琛,杨泽山,娄凯,等.免疫角度比较全胸腔镜与常规开胸在肺癌根治术中的不同[J].医学研究杂志,2013,42(1):107-110.]